21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
Saved in:
| Title: | 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology. |
|---|---|
| Authors: | Mamounas EP; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA. terry.mamounas@orlandohealth.com.; UF Health Cancer Center at Orlando Health, 1400 S., Orange Avenue, MP 700, Orlando, FL, 32806, USA. terry.mamounas@orlandohealth.com., Tang G; NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA., Paik S; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA.; Yonsei University College of Medicine, Seoul, South Korea., Baehner FL; Genomic Health, Inc, Redwood City, CA, USA., Liu Q; NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA., Jeong JH; NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA., Kim SR; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA., Butler SM; Genomic Health, Inc, Redwood City, CA, USA., Jamshidian F; Genomic Health, Inc, Redwood City, CA, USA., Cherbavaz DB; Genomic Health, Inc, Redwood City, CA, USA., Sing AP; Genomic Health, Inc, Redwood City, CA, USA., Shak S; Genomic Health, Inc, Redwood City, CA, USA., Julian TB; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA.; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA., Lembersky BC; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA., Lawrence Wickerham D; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA.; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA., Costantino JP; NRG Oncology and the University of Pittsburgh, Pittsburgh, PA, USA., Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP) (NSABP Legacy trials are now a part of the NRG Oncology portfolio), Pittsburgh, PA, USA.; Allegheny Cancer Center at Allegheny General Hospital, Pittsburgh, PA, USA. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Feb; Vol. 168 (1), pp. 69-77. Date of Electronic Publication: 2017 Nov 11. |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-017-4550-8 |
